ホーム

規制動向

FDA、EMA、TGA および世界の規制動向

#South Korea ×

UPDATED
規制動向
2026年9月15日•1分で読めます
Korean Pharmacists Mobilize Against Expanded Telemedicine Prescription Delivery
The Korean Pharmacists Association plans a launch ceremony on the 9th and a large rally on the 13th in front of the Blue House, opposing the government's plan to expand delivery of prescription drugs for telemedicine.
UPDATED
規制動向
2026年9月14日•1分で読めます
Seoul Pharmacists Association Calls for Fast Legislative Action on Pharmacy Independence and Drug Safety
The Seoul Pharmacists Association delivered a petition to the National Assembly urging prompt review of pending pharmacist‑related bills and stressing safety checks before expanding telemedicine drug delivery.
UPDATED
規制動向
2026年9月14日•1分で読めます
South Korean Lawmaker Proposes Expanding Narcotics Theft‑Prevention Rules to All Controlled Substances
Lawmaker Seo Young‑seok (Democratic Party) introduced a bill to broaden theft‑and‑leak prevention obligations from medical narcotics to all narcotics, including standard substances and raw‑material drugs.
UPDATED
規制動向
2026年9月14日•1分で読めます
South Korea Health and Welfare Committee Schedules Bill Review Subcommittee Meetings for Oct 15‑16
The National Assembly Health and Welfare Committee will hold subcommittee sessions on Oct 15 and 16 to examine health‑related legislation, following a plenary meeting on Oct 11.
UPDATED
規制動向
2026年9月13日•1分で読めます
South Korea Pre‑Pregnancy Support Leaves Thousands Unpaid for Fertility Tests
Analysis of Seoul data shows over 70,000 applicants for fertility test subsidies, but more than 4,000 have not received the test fee payment.
UPDATED
規制動向
2026年9月13日•1分で読めます
Health Insurance Covers Duochem Bio's PSMA PET-CT Test for Prostate Cancer
Duochem Bio's PSMA-targeted PET-CT radiopharmaceutical ‘Prostasic’ is now reimbursed under South Korea’s health insurance, lowering costs for patients with moderate‑to‑high metastasis risk.
UPDATED
規制動向
2026年9月13日•1分で読めます
South Korea’s Global Regulatory Harmonization Center Designated WHO Cooperation Center
The MFDS Global Regulatory Harmonization Center has been named the first WHO‑recognized Cooperation Center for strengthening medical product regulatory systems and training, expanding global harmonization efforts.
UPDATED
規制動向
2026年9月13日•1分で読めます
Seoul Pharmacists Association Raises Concerns Over Lee So-young's Nomination and Telemedicine Drug Delivery Policy
Seoul Pharmacists Association warned that Lee So‑young’s pending appointment as Minister of SMEs and Start‑ups could advance telemedicine and prescription‑drug delivery initiatives, prompting regulatory concerns.
UPDATED
規制動向
2026年9月13日•1分で読めます
Movement Headquarters Criticizes Lee Jae‑myung Govt’s 14.4% Health Insurance Treasury Support
The Lee Jae‑myung administration set next year's health‑insurance national treasury support at 14.4%, prompting strong opposition from the anti‑privatization movement, which says it breaks the president’s 20% pledge.
UPDATED
規制動向
2026年9月13日•1分で読めます
South Korean Government's Plan to Expand Telemedicine Drug Delivery Faces Political Opposition
The government is reviewing a proposal to extend telemedicine prescription drug delivery to all patients, prompting criticism from the Democratic and Progressive parties.
UPDATED
規制動向
2026年9月13日•1分で読めます
South Korean Government Sets 2027 Health Insurance Treasury Support at 13.8 trillion KRW, Union Claims Effective Cut
The government announced a 13.8 trillion KRW national treasury support for 2027 health insurance, but the Health Insurance Labor Union says the increase is insufficient and amounts to a real reduction.
UPDATED
規制動向
2026年9月12日•1分で読めます
Health Insurance False Claims Detected at 839 Korean Clinics and Pharmacies Over Four Years
839 medical institutions in Korea were found to have submitted false health‑insurance claims totaling 34.79 billion won, with clinics accounting for 42.85% of the amount.
1